- For the second quarter ended in September, Aurobindo Pharma recorded a 41% year-over-year fall in its consolidated net profit at 409 crore.
- The drug company’s revenue decreased as well, falling to 5,739 crore from 5,942 crore in the same time last year.
- Aurobindo’s Director Sarath Reddy was detained by the Enforcement Directorate earlier on Thursday for allegedly taking part in the Delhi liquor policy scam.
